1. Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany. Issue 1 (January 2022) Authors: Koeditz, Dominik; Frensch, Juergen; Bierbaum, Martin; Ness, Nils-Henning; Ettle, Benjamin; Vudumula, Umakanth; Gudala, Kapil; Adlard, Nicholas; Tiwari, Santosh; Ziemssen, Tjalf Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 8:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗